Virtus Health Sciences C (RCGHX)
18.95
-0.07 (-0.37%)
USD |
Jul 05 2022
RCGHX Total Assets Under Management: 179.41M for July 5, 2022
Total Assets Under Management Chart
Historical Total Assets Under Management Data
Date | Value |
---|---|
July 05, 2022 | 179.41M |
July 01, 2022 | 180.12M |
June 30, 2022 | 178.58M |
June 29, 2022 | 180.11M |
June 28, 2022 | 178.73M |
June 27, 2022 | 182.12M |
June 24, 2022 | 181.50M |
June 23, 2022 | 177.47M |
June 22, 2022 | 173.55M |
June 21, 2022 | 171.63M |
June 17, 2022 | 167.70M |
June 16, 2022 | 167.18M |
June 15, 2022 | 169.94M |
June 14, 2022 | 168.08M |
June 13, 2022 | 169.38M |
June 10, 2022 | 175.33M |
June 09, 2022 | 178.63M |
June 08, 2022 | 182.90M |
June 07, 2022 | 184.40M |
June 06, 2022 | 181.57M |
June 03, 2022 | 182.20M |
June 02, 2022 | 184.28M |
June 01, 2022 | 181.74M |
May 31, 2022 | 183.97M |
May 27, 2022 | 186.99M |
Date | Value |
---|---|
May 26, 2022 | 183.89M |
May 25, 2022 | 182.45M |
May 24, 2022 | 182.49M |
May 23, 2022 | 182.60M |
May 20, 2022 | 181.75M |
May 19, 2022 | 179.17M |
May 18, 2022 | 178.46M |
May 17, 2022 | 183.91M |
May 16, 2022 | 181.14M |
May 13, 2022 | 179.70M |
May 12, 2022 | 177.15M |
May 11, 2022 | 175.67M |
May 10, 2022 | 178.44M |
May 09, 2022 | 176.32M |
May 06, 2022 | 181.99M |
May 05, 2022 | 183.01M |
May 04, 2022 | 186.28M |
May 03, 2022 | 183.27M |
May 02, 2022 | 182.58M |
April 29, 2022 | 183.38M |
April 28, 2022 | 187.36M |
April 27, 2022 | 186.74M |
April 26, 2022 | 186.53M |
April 25, 2022 | 190.18M |
April 22, 2022 | 186.98M |
Total Assets Under Management Definition
Total Assets Under Management (AUM) is the total market value of the investments that a fund holds.
Total Assets Under Management Range, Past 5 Years
117.73M
Minimum
Mar 23 2020
207.82M
Maximum
Sep 02 2021
167.95M
Average
164.16M
Median
Total Assets Under Management Benchmarks
Rydex Health Care C | 33.70M |
DWS Health and Wellness C | 290.67M |
Saratoga Health & Biotechnology C | 12.59M |
BlackRock Health Sciences Opps Inv C | 9.307B |
Janus Henderson Global Life Sciences C | 4.190B |